I also warned some about the super optimism they were displaying...

It’s only a couple months ago you had a go at me
about being negative. Funny how the worm
turns.

I also warned some about the super optimism
they were displaying about Striate sales and
a partnership 6-12 months ago. One thing
the company claiming they have a fantastic
revolutionary product and another trying to
convince others of the same. It had I think,
about 18months pre Covid reg. approval in
Europe and gained no traction.

IMO, I would suggest, if holders have not got the
patience to wait another few years for reg.
approval and market inroads by Celgro nerve,
then it’s time to jump ship. Maybe invest in
banks. That’s the only consolation I have. If I
had invested in banks when I bought OCC, I
wouldn’t be much better off.

Looks more and more likely we have missed
the ATI boat.